Literature DB >> 28188078

Travelling abroad with cystic fibrosis: Assessment of risks and healthcare requirements.

Rachel Miller1, Laura Blanch1, Sarah Lenaghan1, Alan Anderson1, Simon Doe1, Stephen J Bourke2.   

Abstract

There is limited information on the risks and healthcare requirements of patients with cystic fibrosis (CF) undertaking travel abroad. Of 100 patients (mean age 24.7 years, mean FEV1 57.3 %predicted) attending a UK adult CF Centre, 96% had travelled abroad but 14% now limited travel on medical advice. They travelled frequently and widely, often undertaking adventurous activities on holidays, but because of the costs involved, 18% travelled without travel insurance and 23% with insurance which did not cover CF. Of those who had ever had an illness abroad 10% had a CF-related illness (7 chest infection, 2 dehydration, 1 pancreatitis) and 12% a non-CF-related illness (4 sunburn, 3 gastroenteritis, 3 ear infection, 1 fall, 1 gastro-oesophageal reflux). There is a wide range of disease severity and assessment of the medical risks and the travel insurance premium to be charged should be based on the individual's health status rather than generically on the basis of a diagnosis of CF.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cystic fibrosis; Healthcare requirements; Risk assessment; Travel; Travel insurance

Mesh:

Year:  2017        PMID: 28188078     DOI: 10.1016/j.rmed.2017.01.007

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  1 in total

1.  CONCERNS FOR PEOPLE WITH CYSTIC FIBROSIS (PWCF) WHEN TRAVELLING PRE COVID-19.

Authors:  Megan O'Doherty; Damian O'Neill; Jacqueline C Rendall; John E Moore; Beverley C Millar
Journal:  Ulster Med J       Date:  2022-02-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.